We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPRO icon
1801
ProShares UltraPro S&P 500
UPRO
$5.7B
$24K ﹤0.01%
1,384
-79,614
-98% -$1.79M
WATT icon
1802
Energous
WATT
$102M
$24K ﹤0.01%
+7
New +$34.1K
ATRI
1803
DELISTED
Atrion Corp
ATRI
$24K ﹤0.01%
33
-49
-60% -$35K
CLRG
1804
DELISTED
IndexIQ ETF Trust IQ U.S. Large Cap ETF
CLRG
$24K ﹤0.01%
+1,116
New +$26.7K
MTEM
1805
DELISTED
Molecular Templates, Inc.
MTEM
$24K ﹤0.01%
400
-179
-31% -$12.5K
ISEE
1806
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$24K ﹤0.01%
19,550
+6,601
+51% +$12.8K
PFBI
1807
DELISTED
Premier Financial Bancorp
PFBI
$24K ﹤0.01%
1,643
+235
+17% +$4.11K
LMNX
1808
DELISTED
Luminex Corp
LMNX
$24K ﹤0.01%
+1,047
New +$28.2K
TLRA
1809
DELISTED
Telaria, Inc.
TLRA
$24K ﹤0.01%
8,719
+4,713
+118% +$13.6K
NRE
1810
DELISTED
NorthStar Realty Europe Corp.
NRE
$24K ﹤0.01%
+1,639
New +$24.2K
PETX
1811
DELISTED
Aratana Therapeutics, Inc.
PETX
$24K ﹤0.01%
3,836
+3,076
+405% +$18.8K
FTR
1812
DELISTED
Frontier Communications Corp.
FTR
$24K ﹤0.01%
10,280
+4,232
+70% +$17.9K
AMRX icon
1813
Amneal Pharmaceuticals
AMRX
$5.79B
$23K ﹤0.01%
+1,700
New +$30.6K
BJRI icon
1814
BJ's Restaurants
BJRI
$1.48B
$23K ﹤0.01%
459
+305
+198% +$18.4K
CBRL icon
1815
Cracker Barrel
CBRL
$1.29B
$23K ﹤0.01%
142
-1,424
-91% -$234K
CHE icon
1816
Chemed
CHE
$7.22B
$23K ﹤0.01%
82
-2,112
-96% -$637K
CRK icon
1817
Comstock Resources
CRK
$3.94B
$23K ﹤0.01%
5,099
+4,321
+555% +$31.7K
DOO
1818
Bombardier Recreational Products
DOO
$4.77B
$23K ﹤0.01%
+886
New +$32K
ELP
1819
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$23K ﹤0.01%
+7,455
New +$22K
GBLI icon
1820
Global Indemnity Group
GBLI
$23K ﹤0.01%
639
+541
+552% +$19K
GMED icon
1821
Globus Medical
GMED
$11.2B
$23K ﹤0.01%
550
-4,849
-90% -$242K
JBSS icon
1822
John B. Sanfilippo & Son
JBSS
$972M
$23K ﹤0.01%
407
+216
+113% +$13.9K
LBRDA icon
1823
Liberty Broadband Class A
LBRDA
$5.16B
$23K ﹤0.01%
318
-110
-26% -$8.83K
LMNR icon
1824
Limoneira
LMNR
$251M
$23K ﹤0.01%
+1,159
New +$27.4K
MMS icon
1825
Maximus
MMS
$3.1B
$23K ﹤0.01%
357
-6,770
-95% -$446K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.